Intelligent way,maybe how management handled some things in the past,could have been done a little differently ,who knows,but if PRR can manage to get even just one drug to blockbuster status in the coming years ,the past will be forgotten and the faithful long term holders will be rewarded justly..as for cvac ,although to date ,no sale or jv of the product has been announced ,sure,but sometimes ,taking a little longer can lead to achieving a better outcome ,as the company wouldn't want to flog it off cheaply as it has invested a lot of time and money into the product,,for mine the product appears to be one of the safest available ,and on last reports o/s still hadn't been reached,it's hard to ignore these results ,,,just my thoughts..DYOR
PRR Price at posting:
5.3¢ Sentiment: Buy Disclosure: Held
(20min delay)